E4A Systemic Mastocytosis/Emerging Indication HEOR Strategy Specialist

This role leads US-focused Health Economic and Outcomes Research activities for AYVAKIT in Systemic Mastocytosis and emerging pipeline assets within the US Rare/Oncology HEVA team. The position involves designing and executing HEOR studies, translating evidence into US business and policy impact, and supporting payer engagement and access strategies. The specialist collaborates with multi-functional teams to ensure clinical and real-world evidence programs meet US reimbursement standards and support lifecycle management.